- Gap Filling Done
- Trendline tested 4 times i.e. weakening
- Two Dojis at the gap zone indicating indecision
- A good bullish sign here can mean a potential up move
- Given that the pharma sector hasn't performed in the last year, we may see some momentum in the coming period.
DISCLAIMER: We are not registered. We are not advisors. Everything here is merely for educational purposes and is a purely personal opinion. Please consult your advisor before investing.
- Trendline tested 4 times i.e. weakening
- Two Dojis at the gap zone indicating indecision
- A good bullish sign here can mean a potential up move
- Given that the pharma sector hasn't performed in the last year, we may see some momentum in the coming period.
DISCLAIMER: We are not registered. We are not advisors. Everything here is merely for educational purposes and is a purely personal opinion. Please consult your advisor before investing.
Nota
12% in already. Booked part profits.Now we await the trendline breakout. We may hit the Moon.
Nota
25% IN !! 🚀🚀🚀🚀Nota
Another 5% Booster. We have now reached a resistance zone.Nota
Divis is Consolidating at the resistance zone. The Psy. Level of 4000 can be a major hurdle🎯 You can now access our personal charts for all Nifty 500 companies📈
👉 Visit nas.io/TradeWithTc to learn Price Action with real life case studies.
#BeYourOwnAnalyst
👉 Visit nas.io/TradeWithTc to learn Price Action with real life case studies.
#BeYourOwnAnalyst
Penafian
Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.
🎯 You can now access our personal charts for all Nifty 500 companies📈
👉 Visit nas.io/TradeWithTc to learn Price Action with real life case studies.
#BeYourOwnAnalyst
👉 Visit nas.io/TradeWithTc to learn Price Action with real life case studies.
#BeYourOwnAnalyst
Penafian
Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.